These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9723518)

  • 21. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production.
    van den Berg AP; Twilhaar WN; Mesander G; van Son WJ; van der Bij W; Klompmaker IJ; Slooff MJ; The TH; de Leij LH
    Transplantation; 1998 Apr; 65(8):1066-71. PubMed ID: 9583867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everolimus (Certican) in combination with neoral in pediatric renal transplant recipients: interim analysis after 3 months.
    Vester U; Kranz B; Wehr S; Boger R; Hoyer PF;
    Transplant Proc; 2002 Sep; 34(6):2209-10. PubMed ID: 12270366
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression.
    Goggins WC; Fisher RA; Dattilo JB; Cohen DS; Tawes JW; Dattilo MP; Babcock GF; Frede SE; Wakely PE; Posner MP
    Transplantation; 1997 Jan; 63(2):310-4. PubMed ID: 9020336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients.
    Gong N; Chen Z; Wang J; Fang A; Li Y; Xiang Y; Ming C; Zhang W
    Cell Immunol; 2015 Oct; 297(2):87-93. PubMed ID: 26205091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry.
    Stinn JL; Taylor MK; Becker G; Nagano H; Hasegawa S; Furakawa Y; Shimizu K; Libby P; Mitchell RN
    Am J Pathol; 1998 Nov; 153(5):1383-92. PubMed ID: 9811329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of kidney graft acceptance by creating a window of opportunity for immunologic engagement (WOFIE) in rhesus monkeys.
    Jonker M; Slingerland W; Ossevoort M; Kuhn E; Neville D; Friend P; Calne R
    Transplant Proc; 1998 Aug; 30(5):2441-3. PubMed ID: 9723530
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporine Neoral profiling in Japanese renal transplant recipients.
    Aikawa A; Arai K; Tajima E; Kawamura T; Ogiwara H; Sakai K; Mizuiri S; Ohara T; Hasegawa A; Kosugi T; Kusano A; Matsuo K; Obayashi M; Kurokawa M
    Transplant Proc; 2001; 33(7-8):3142-5. PubMed ID: 11750350
    [No Abstract]   [Full Text] [Related]  

  • 28. Experience with conversion from Sandimmun to Neoral cyclosporine and the correlation of C2 levels with renal function.
    Konstadinidou I; Boletis JN
    Transplant Proc; 2004 Mar; 36(2 Suppl):163S-166S. PubMed ID: 15041329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 30. The macrolide SDZ RAD is efficacious in a nonhuman primate model of allotransplantation.
    Schuurman HJ; Schuler W; Ringers J; Jonker M
    Transplant Proc; 1998 Aug; 30(5):2198-9. PubMed ID: 9723439
    [No Abstract]   [Full Text] [Related]  

  • 31. Concentration control: a key to phase I development of immunosuppressive agents.
    Kahan BD
    Transplant Proc; 1994 Dec; 26(6):3203-4. PubMed ID: 7998116
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.
    Oellerich M; Armstrong VW; Streit F; Weber L; Tönshoff B
    Clin Biochem; 2004 Jun; 37(6):424-8. PubMed ID: 15183289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperlipidemia in renal transplant recipients treated with sirolimus (rapamycin).
    Brattström C; Wilczek H; Tydén G; Böttiger Y; Säwe J; Groth CG
    Transplantation; 1998 May; 65(9):1272-4. PubMed ID: 9603181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus rescue therapy for refractory rejection in renal transplant recipients.
    Hong JC; Kahan BD
    Transplant Proc; 2001; 33(1-2):1033. PubMed ID: 11267178
    [No Abstract]   [Full Text] [Related]  

  • 35. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cells.
    Barkis I; Hadjiyannaki-Koniavitou K; Vareltzides A; Hornung N; Raskova J; Degiannis D
    Transplant Proc; 1995 Feb; 27(1):432-4. PubMed ID: 7879050
    [No Abstract]   [Full Text] [Related]  

  • 37. Sirolimus inhibits oxidative burst activity in transplant recipients.
    Gee I; Trull AK; Charman SC; Alexander GJ
    Transplantation; 2003 Dec; 76(12):1766-8. PubMed ID: 14688530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapamycin and cyclosporine A treatment: a novel regimen to prevent chronic allograft rejection in sensitized hosts.
    Wasowska B; Hancock WW; Onodera K; Korom S; Stadlbauer TH; Zheng XX; Strom TB; Kupiec-Weglinski JW
    Transplant Proc; 1997; 29(1-2):333. PubMed ID: 9123026
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
    Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET
    Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of in vivo rapamycin treatment on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat.
    Damoiseaux JG; Beijleveld LJ; Schuurman HJ; van Breda Vriesman PJ
    Transplantation; 1996 Oct; 62(7):994-1001. PubMed ID: 8878395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.